233 related articles for article (PubMed ID: 25220369)
1. Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans.
Kierkels RG; Korevaar EW; Steenbakkers RJ; Janssen T; van't Veld AA; Langendijk JA; Schilstra C; van der Schaaf A
Radiother Oncol; 2014 Sep; 112(3):430-6. PubMed ID: 25220369
[TBL] [Abstract][Full Text] [Related]
2. Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.
Kierkels RGJ; Wopken K; Visser R; Korevaar EW; van der Schaaf A; Bijl HP; Langendijk JA
Radiother Oncol; 2016 Dec; 121(3):374-380. PubMed ID: 27614681
[TBL] [Abstract][Full Text] [Related]
3. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
[TBL] [Abstract][Full Text] [Related]
4. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.
Christianen ME; van der Schaaf A; van der Laan HP; Verdonck-de Leeuw IM; Doornaert P; Chouvalova O; Steenbakkers RJ; Leemans CR; Oosting SF; van der Laan BF; Roodenburg JL; Slotman BJ; Bijl HP; Langendijk JA
Radiother Oncol; 2016 Feb; 118(2):298-303. PubMed ID: 26700602
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and toxicity guided treatment plan optimisation for head and neck cancer.
van der Laan HP; van der Schaaf A; Van den Bosch L; Korevaar EW; Steenbakkers RJHM; Both S; Langendijk JA
Radiother Oncol; 2021 Sep; 162():85-90. PubMed ID: 34237344
[TBL] [Abstract][Full Text] [Related]
6. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
7. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
8. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study.
van der Laan HP; Christianen ME; Bijl HP; Schilstra C; Langendijk JA
Radiother Oncol; 2012 Apr; 103(1):76-81. PubMed ID: 22112778
[TBL] [Abstract][Full Text] [Related]
9. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
10. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW
PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987
[TBL] [Abstract][Full Text] [Related]
11. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.
Chang JH; Wada M; Anderson NJ; Lim Joon D; Lee ST; Gong SJ; Gunawardana DH; Sachinidis J; O'Keefe G; Gan HK; Khoo V; Scott AM
Acta Oncol; 2013 Nov; 52(8):1723-9. PubMed ID: 23317145
[TBL] [Abstract][Full Text] [Related]
13. The dosimetric and radiobiological impact of calculation grid size on head and neck IMRT.
Srivastava SP; Cheng CW; Das IJ
Pract Radiat Oncol; 2017; 7(3):209-217. PubMed ID: 27847266
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.
Lalonde A; Bobić M; Sharp GC; Chamseddine I; Winey B; Paganetti H
Phys Med Biol; 2023 May; 68(11):. PubMed ID: 37164020
[No Abstract] [Full Text] [Related]
15. Composite minimax robust optimization of VMAT improves target coverage and reduces non-target dose in head and neck cancer patients.
Wagenaar D; Kierkels RGJ; Free J; Langendijk JA; Both S; Korevaar EW
Radiother Oncol; 2019 Jul; 136():71-77. PubMed ID: 31015132
[TBL] [Abstract][Full Text] [Related]
16. An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma.
Feng Z; Tao C; Zhu J; Chen J; Yu G; Qin S; Yin Y; Li D
Radiat Oncol; 2017 Apr; 12(1):64. PubMed ID: 28376900
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients.
Kanehira T; van Kranen S; Jansen T; Hamming-Vrieze O; Al-Mamgani A; Sonke JJ
Radiother Oncol; 2021 Nov; 164():209-215. PubMed ID: 34619234
[TBL] [Abstract][Full Text] [Related]
18. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
19. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction.
van der Laan HP; Gawryszuk A; Christianen ME; Steenbakkers RJ; Korevaar EW; Chouvalova O; Wopken K; Bijl HP; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):282-7. PubMed ID: 23742959
[TBL] [Abstract][Full Text] [Related]
20. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
